NewAmsterdam Pharma Company N.V. company logo
NewAmsterdam Pharma Company N.V. logo

NAMS Long Term Liabilities

Annual Long Term Liabilities

$202.00K$8.61M-97.71%

Summary

Current Value
As of today, NAMS annual long term liabilities is $202.00K, down -97.71% on
Historical Performance
NAMS annual long term liabilities is up +60.70% over the past 3 years, and up +100.00% over the past 5 years
All-Time High Comparison
NAMS annual long term liabilities is currently -98.37% below its historical high of $12.37M set on
3-Year Low Comparison
NAMS annual long term liabilities is at its 3-year low
Sector Comparison
NAMS annual long term liabilities is higher than 15.52% of companies in Healthcare sector

Long Term Liabilities Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NAMS Performance
MetricDateValue1Y3Y5Y15Y
Annual Long Term Liabilities$202.00K-97.7%+60.7%+100.0%+100.0%
Quarterly Long Term Liabilities$85.00K-99.5%-99.0%-99.3%-99.3%
Price$35.81+40.1%+211.1%
Annual Long Term Debt$202.00K+100.0%+60.7%+100.0%+100.0%
Annual Total Liabilities$107.12M+82.5%+1262.0%+763.3%+763.3%
Annual Current Liabilities$106.92M+114.3%+855.8%+578.7%+578.7%
Annual Non Current Assets$1.21M+294.4%+17.4%+8055.4%+8055.4%
Annual Total Assets$864.62M+149.1%+519.8%+518.2%+518.2%

Long Term Liabilities Highs

NAMS Annual Long Term Liabilities Highs Comparison
PeriodHighDateCurrent
3Y$12.37MN/A-98.4%
5Y$12.37M-98.4%
All$12.37M-98.4%

Long Term Liabilities Lows

NAMS Annual Long Term Liabilities Lows Comparison
PeriodLowDateCurrent
3Y$202.00Kat low
5Y$0.00N/AN/A
All$0.00N/A

Long Term Liabilities History

YearValueChange
$202.00K-97.7%
$8.81M-28.8%
$12.37M+9,744.1%
YearValueChange
$125.70K>+9,900.0%
$0.00-

FAQ

  • What is the current annual long term liabilities of NAMS?

    As of today, NAMS annual long term liabilities is $202.00K

  • What is 1-year change in NAMS annual long term liabilities?

    NAMS annual long term liabilities is down -97.71% year-over-year

  • What is 3-year change in NAMS annual long term liabilities?

    NAMS annual long term liabilities is up +60.70% over the past 3 years

  • How far is NAMS annual long term liabilities from its all-time high?

    NAMS annual long term liabilities is currently -98.37% below its historical high of $12.37M set on December 31, 2022

  • How does NAMS annual long term liabilities rank versus sector peers?

    NAMS annual long term liabilities is higher than 15.52% of companies in Healthcare sector

  • When is NAMS next annual earnings release?

    The next annual earnings release for NAMS is on

Long Term Liabilities Formula

Long-Term Liabilities = + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

Data Sources & References

  1. NAMS Official Website www.newamsterdampharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1936258/000119312525265796/0001193125-25-265796-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1936258/000095017025027339/0000950170-25-027339-index.htm
  4. NAMS Profile on Yahoo Finance finance.yahoo.com/quote/NAMS
  5. NAMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nams